8-KEarnings & ResultsExhibits & Filings

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (Jan 27, 2006)

Filed January 27, 2006For Securities:IDXX

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K on January 27, 2006, to report its financial results for the fourth quarter and full year ended December 31, 2005. The primary purpose of this filing is to furnish the press release containing these results, which are not considered officially 'filed' for purposes of Section 18 of the Exchange Act but are provided for informational purposes. Investors should refer to the press release, furnished as Exhibit 99.1, for detailed financial performance and operational updates for the period. The company is informing the market about its year-end financial condition and operational outcomes. While the 8-K itself is a procedural document for this announcement, the underlying press release is the critical source of information for understanding IDXX's performance, including revenue, profitability, and any forward-looking statements or guidance provided by management.

Key Highlights

  • 1IDEXX Laboratories, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2005.
  • 2The report is an 8-K filing dated January 27, 2006.
  • 3The financial results were disclosed via a press release, furnished as Exhibit 99.1.
  • 4The filing is primarily for informational purposes regarding financial condition and results of operations.
  • 5Information furnished under Item 2.02 is not deemed 'filed' for Section 18 purposes.
  • 6The CFO, Merilee Raines, signed the report, indicating its financial nature.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and furnish IDEXX Laboratories, Inc.'s financial results for the fourth quarter and the full fiscal year ended December 31, 2005, through an accompanying press release.

The detailed financial results are contained in the press release titled 'IDEXX Laboratories Announces Fourth Quarter Results,' which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this press release for comprehensive information.

According to the filing, the information furnished under Item 2.02, including the press release, is being furnished and shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. It is provided for informational purposes.

Merilee Raines, Vice President, Chief Financial Officer and Treasurer, is identified as the Principal Financial and Accounting Officer who signed the report on behalf of IDEXX Laboratories, Inc., indicating her oversight of these financial disclosures.